Association between progesterone treatment and neonatal outcome in preterm births: a retrospective analysis

References

• Amaral LM, Cornelius DC, Harmon A, Moseley J, Martin JN, LaMarca B, et al. 2015. B. 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension 65:225–231.
   PubMed Web of Science ®Google Scholar
• De Franco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, et al. 2007. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound in Obstetrics and Gynecology 30:697–705.
   PubMed Web of Science ®Google Scholar
• Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon E-S. 2005. Birth weight standards in the live-born population in Israel. The Israel Medical Association Journal 7:311–314.
   PubMed Web of Science ®Google Scholar
• Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH 2007. Progesterone and the risk of preterm birth among women with a short cervix. The New England Journal of Medicine 357:462–469.
   PubMed Web of Science ®Google Scholar
• Fukuyama A, Tanaka K, Kakizaki I, Kasai K, Chiba M, Nakamura T, et al. 2012. Anti-inflammatory effect of proteoglycan and progesterone on human uterine cervical fibroblasts. Life Sciences 90:484–488.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, Romero R. 2008. Epidemiology and causes of preterm birth. Lancet 371:75–84.
   PubMed Web of Science ®Google Scholar
• Gursahaney PR, Meyn LA, Hillier SL, Sweet RL, Wiesenfeld HC. 2010. Combined hormonal contraception may be protective against Neisseria gonorrhoeae infection. Sexually Transmitted Diseases 37:356–360.
   PubMed Web of Science ®Google Scholar
• Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M et al. 2011. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound in Obstetrics & Gynecology 38:18–31.
   PubMed Web of Science ®Google Scholar
• Jacobson JC, Turok DK, Dermish AI, Nygaard IE, Settles ML. 2014. Vaginal microbiome changes with levonorgestrel intrauterine system placement. Contraception 90:130–135.
   PubMed Web of Science ®Google Scholar
• Kindinger LM, Bennett PR, Lee YS, Marchesi JR, Smith A, Cacciatore S, et al. 2017. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome 5:6.
   PubMed Web of Science ®Google Scholar
• Ma'ayeh M, Rood KM, Walker HC, Oliver EA, Gee SE, Iams JD, et al. 2019. Vaginal progesterone is associated with decreased group B streptococcus colonisation at term: a retrospective cohort study. British Journal of Obstetrics & Gynaecology 126:1141–1147.
   Google Scholar
• Mattison DR, Damus K, Fiore E, Petrini J, Alter C. 2001. Preterm delivery: a public health perspective. Paediatric and Perinatal Epidemiology 15: 7–16.
   PubMed Web of Science ®Google Scholar
• Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. 2003. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. The New England Journal of Medicine 348:2379–2385.
   PubMed Web of Science ®Google Scholar
• Paneth NS. 1995. The problem of low birth weight. The Future of Children 5:19–34.
   PubMed Web of Science ®Google Scholar
• Payne MS, Bayatibojakhi S. 2014. Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome. Frontiers in Immunology 5:595.
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Mukhopadhyay S, Hansen NI, Cotten CM, Stoll BJ, Sanchez PJ, et al. 2017. Identification of extremely premature infants at low risk for early-onset sepsis. Pediatrics 140:e20170925.
   PubMed Web of Science ®Google Scholar
• Romero R, Conde-Agudelo A, Da Fonseca E, O’Brien JM, Cetingoz E, Creasy GW, et al. 2018. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. American Journal of Obstetrics and Gynecology 218:161–180.
   PubMed Web of Science ®Google Scholar
• Romero R, Gomez-Lopez N, Winters AD, Jung E, Shaman M, Bieda J, et al. 2019. Evidence that intra-amniotic infections are often the result of an ascending invasion – a molecular microbiological study. Journal of Perinatal Medicine 47:915–931.
   PubMed Web of Science ®Google Scholar
• Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. 2014. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2:4.
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides KH, Conde‐Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, et al. 2016. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound in Obstetrics & Gynecology 48:308–317.
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. 2004. Pharmacological profile of progestins. Maturitas 47:277–283.
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L, et al. 2001. Progesterone as an immunomodulatory molecule. International Immunopharmacology 1:1037–1048.
   PubMed Web of Science ®Google Scholar
• Ville Y, Rozenberg P. 2018. Predictors of preterm birth. Best Practice & Research Clinical Obstetrics & Gynaecology 52:23–32.
   PubMed Web of Science ®Google Scholar
• Vodstrcil LA, Hocking JS, Law M, Walker S, Tabrizi SN, Fairley CK, et al. 2013. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLOS One 8:e73055.
   PubMed Web of Science ®Google Scholar
• Xu L, Dong B, Wang H, Zeng Z, Liu W, Chen N, et al. 2013. Progesterone suppresses Th17 cell responses, and enhances the development of regulatory T cells, through thymic stromal lymphopoietin-dependent mechanisms in experimental gonococcal genital tract infection. Microbes and Infection 15:796–805.
   PubMed Web of Science ®Google Scholar